Your browser doesn't support javascript.
loading
Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara, Roberto; Imbimbo, Martina; Malouf, Reem; Paget-Bailly, Sophie; Calais, François; Marchal, Corynne; Westeel, Virginie.
Afiliação
  • Ferrara R; Thoracic Oncology Unit, Fondazione IRCSS Istituto Nazionale dei Tumori, Milano, Italy.
  • Imbimbo M; Department of Oncology, Lausanne University Hospital, and Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.
  • Malouf R; National Perinatal Epidemiology Unit (NPEU), University of Oxford, Oxford, UK.
  • Paget-Bailly S; Methodological and Quality of Life in Oncology Unit, University Hospital of Besançon, Besançon, France.
  • Calais F; Université de Franche-Comté, INSERM, EFS BFC, UMR 1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Besançon, France, Besançon, France.
  • Marchal C; Bibliothèque universitaire de Santé, Université de Franche-Comté, Besançon, France.
  • Westeel V; Université de Franche-Comté, Besançon, France.
Cochrane Database Syst Rev ; 4: CD013257, 2021 04 30.
Article em En | MEDLINE | ID: mdl-33930176

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Bevacizumab / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Bevacizumab / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares Idioma: En Ano de publicação: 2021 Tipo de documento: Article